BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 3486634)

  • 1. [Neo-adjuvant therapy in childhood osteogenic sarcoma: a pilot study of selective postoperative chemotherapy based on response to preoperative high-dose methotrexate].
    Sasaki K; Matsuoka H; Murakami T; Fujimoto T; Takayanagi F; Sawai K; Niwa J; Hara K
    Gan To Kagaku Ryoho; 1986 May; 13(5):1837-45. PubMed ID: 3486634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors in the response of primary osteogenic sarcoma to preoperative chemotherapy (high-dose methotrexate with citrovorum factor).
    Juergens H; Kosloff C; Nirenberg A; Mehta BM; Huvos AG; Rosen G
    Natl Cancer Inst Monogr; 1981 Apr; (56):221-6. PubMed ID: 6975439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can cure in patients with osteosarcoma be achieved exclusively with chemotherapy and abrogation of surgery?
    Jaffe N; Carrasco H; Raymond K; Ayala A; Eftekhari F
    Cancer; 2002 Nov; 95(10):2202-10. PubMed ID: 12412175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The importance of dose intensity in preoperative chemotherapy for osteosarcoma--retrospective analysis of a short intensive chemotherapy regimen preoperatively using high-dose methotrexate and cisplatinum].
    Takahashi M; Katagiri H; Sato K; Sugiura H; Yamamura S; Fukaya N; Nakanishi K
    Gan To Kagaku Ryoho; 1994 Mar; 21(4):459-64. PubMed ID: 8129386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose methotrexate with citrovorum factor in osteogenic sarcoma--progress report II.
    Jaffe N; Frei E; Traggis D; Cassady JR; Watts H; Filler RM
    Cancer Treat Rep; 1977 Jul; 61(4):675-9. PubMed ID: 301780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of osteogenic sarcoma. I. Effect of adjuvant high-dose methotrexate after amputation.
    Rosenburg SA; Chabner BA; Young RC; Seipp CA; Levine AS; Costa J; Hanson TA; Head GC; Simon RM
    Cancer Treat Rep; 1979 May; 63(5):739-51. PubMed ID: 313245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telangiectatic osteogenic sarcoma. Improved survival with combination chemotherapy.
    Rosen G; Huvos AG; Marcove R; Nirenberg A
    Clin Orthop Relat Res; 1986 Jun; (207):164-73. PubMed ID: 2424660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Surgery and adjuvant chemotherapy of osteosarcoma].
    Yamawaki S
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1576-83. PubMed ID: 3460527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [High-dose methotrexate with citrovorum factor rescue (HD-MTX-CFR) in the treatment of malignant solid tumors--clinical analysis of 62 patients].
    Wang QL; Sun Y; Zhou JC; Song SZ; Feng FY; Lu L; Yie ZS
    Zhonghua Zhong Liu Za Zhi; 1988 Mar; 10(2):152-4. PubMed ID: 3264785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative administration of high-dose methotrexate for osteosarcoma.
    Chan KW; Knowling MA; Duncan CP; Morton KS
    Can J Surg; 1984 May; 27(3):305-7, 309. PubMed ID: 6586272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant chemotherapy for osteogenic sarcoma.
    Etcubanas E; Wilbur JR
    Cancer Treat Rep; 1978 Feb; 62(2):283-7. PubMed ID: 346218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preoperative and postoperative chemotherapy of osteogenic sarcoma of the limbs in children].
    Muñoz Villa A; Ocete G; Aymerich ML; Maldonado S; Otheo E; Calvo M; Amaya J
    Med Clin (Barc); 1996 Jun; 107(5):161-4. PubMed ID: 8758673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The results of using high-dose methotrexate in treating osteogenic sarcoma].
    Perevodchikova NI; Eremina LA; Manziuk LV; Siniukov PA; Fedenko AN; Singin AS; Moldovanova LK
    Vopr Onkol; 1990; 36(6):667-71. PubMed ID: 2378085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant therapy for osteosarcoma: preoperative and postoperative treatment.
    Eilber FR; Grant T; Morton DL
    Cancer Treat Rep; 1978 Feb; 62(2):213-6. PubMed ID: 346209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteogenic sarcoma: eight-percent, three-year, disease-free survival with combination chemotherapy (T-7).
    Rosen G; Nirenberg A; Caparros B; Juergens H; Kosloff C; Mehta BM; Marcove RC; Huvos AG
    Natl Cancer Inst Monogr; 1981 Apr; (56):213-20. PubMed ID: 6946291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of high-dose methotrexate and vincristine on ovarian and testicular functions in patients undergoing postoperative adjuvant treatment of osteosarcoma.
    Shamberger RC; Rosenberg SA; Seipp CA; Sherins RJ
    Cancer Treat Rep; 1981; 65(9-10):739-46. PubMed ID: 6791818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraarterial Cisplatin and intravenous adriamycin in nonmetastatic osteosarcoma of the extremities: a single institution experience in Taiwan.
    Chiu TJ; Wang JW; Chen YJ; Tang Y; Huang CH
    Chang Gung Med J; 2009; 32(1):72-80. PubMed ID: 19292942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteogenic sarcoma: state of the art with high-dose methotrexate treatment.
    Jaffe N
    Clin Orthop Relat Res; 1976 Oct; (120):95-102. PubMed ID: 1086179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteogenic sarcoma of the extremity with detectable lung metastases at presentation. Results of treatment of 23 patients with chemotherapy followed by simultaneous resection of primary and metastatic lesions.
    Bacci G; Mercuri M; Briccoli A; Ferrari S; Bertoni F; Donati D; Monti C; Zanoni A; Forni C; Manfrini M
    Cancer; 1997 Jan; 79(2):245-54. PubMed ID: 9010097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose methotrexate and leucovorin rescue in dogs with osteogenic sarcoma.
    Cotter SM; Parker LM
    Am J Vet Res; 1978 Dec; 39(12):1943-5. PubMed ID: 312044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.